Novozymes Total Liabilities 2011-2024 | NVZMY
Novozymes total liabilities from 2011 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Novozymes total liabilities for the quarter ending June 30, 2024 were $2.039B, a 4.67% increase year-over-year.
- Novozymes total liabilities for 2024 were $4.35B, a 113.36% increase from 2023.
- Novozymes total liabilities for 2023 were $2.039B, a 4.67% increase from 2022.
- Novozymes total liabilities for 2022 were $1.948B, a 2.54% decline from 2021.
Novozymes Annual Total Liabilities
(Millions of US $) |
| 2024 |
$4,350 |
| 2023 |
$2,039 |
| 2022 |
$1,948 |
| 2021 |
$1,998 |
| 2020 |
$1,420 |
| 2019 |
$1,343 |
| 2018 |
$1,308 |
| 2017 |
$1,079 |
| 2016 |
$1,027 |
| 2015 |
$922 |
| 2014 |
$1,274 |
| 2013 |
$952 |
| 2012 |
$958 |
| 2011 |
$938 |
| 2010 |
$849 |
Novozymes Quarterly Total Liabilities
(Millions of US $) |
| 2023-12-31 |
$2,039 |
| 2023-09-30 |
$1,993 |
| 2023-06-30 |
$2,108 |
| 2023-03-31 |
$2,161 |
| 2022-12-31 |
$1,948 |
| 2022-09-30 |
$1,885 |
| 2022-06-30 |
$2,002 |
| 2022-03-31 |
$2,050 |
| 2021-12-31 |
$1,998 |
| 2021-09-30 |
$1,625 |
| 2021-06-30 |
$1,735 |
| 2021-03-31 |
$1,767 |
| 2020-12-31 |
$1,420 |
| 2020-09-30 |
$1,463 |
| 2020-06-30 |
$1,461 |
| 2020-03-31 |
$1,427 |
| 2019-12-31 |
$1,343 |
| 2019-09-30 |
$1,333 |
| 2019-06-30 |
$1,361 |
| 2019-03-31 |
$1,440 |
| 2018-12-31 |
$1,308 |
| 2018-09-30 |
$1,254 |
| 2018-06-30 |
$1,303 |
| 2018-03-31 |
$1,370 |
| 2017-12-31 |
$1,079 |
| 2017-09-30 |
$1,157 |
| 2017-06-30 |
$1,092 |
| 2017-03-31 |
$1,134 |
| 2016-12-31 |
$1,027 |
| 2016-09-30 |
$1,026 |
| 2016-06-30 |
$1,032 |
| 2016-03-31 |
$1,019 |
| 2015-12-31 |
$922 |
| 2015-09-30 |
$1,017 |
| 2015-06-30 |
$1,057 |
| 2015-03-31 |
$1,092 |
| 2014-12-31 |
$1,274 |
| 2014-09-30 |
$1,387 |
| 2014-06-30 |
$1,356 |
| 2014-03-31 |
$1,292 |
| 2013-12-31 |
$952 |
| 2013-09-30 |
$947 |
| 2013-06-30 |
$1,059 |
| 2013-03-31 |
$1,153 |
| 2012-12-31 |
$958 |
| 2012-09-30 |
$896 |
| 2012-06-30 |
$917 |
| 2012-03-31 |
$890 |
| 2011-12-31 |
$938 |
| 2011-09-30 |
$1,001 |
| 2011-06-30 |
$977 |
| 2011-03-31 |
$981 |
| 2010-12-31 |
$849 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$32.823B |
$4.149B |
|
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
|
